Lynx Capital Who We Are Our Portfolio Portfolio News Contact Us Lynx Capital 德石资本 Healthcare Focus, Global Resource, China Angle Who We Are Lynx Capital is a healthcare and life science -focused fund, investing in innovative companies in western countries in both therapeutics and medical technology areas, with a potential to collaborate with Chinese companies to explore the China market. With the extensive expertise and experience in both China and the States, and deep understanding of healthcare and business, Lynx Capital believes that it is well positioned to help with such collaboration. Our Portfolio Companies Portfolio News Mobidiag ESPOO, Finland, April 08, 2021 – Mobidiag to Be Acquired by Hologic, Innovator in Women’s Health Diagnostic Testing, for Approximately €668 Million Reviva NEW YORK and CUPERTINO, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) – Reviva Pharmaceuticals, Inc. and Tenzing Acquisition Corp. Complete their Business Combination and Trade as Reviva Pharmaceuticals Holdings, Inc Exicure CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov. 14, 2019-- Exicure, Inc., (NASDAQ:XCUR) and Allergan Enter Into Collaboration, Option and License Agreement to Discover and Develop SNA-based Treatments for Hair Loss Disorders Mobidiag ESPOO, Finland, October 09, 2019 – NEW! Novodiag® Stool Parasites, comprehensive and cost-effective molecular diagnostic test for detection of intestinal parasite Aridis SAN JOSE, Calif., Sept. 30, 2019 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), Executes License Agreement with The Serum Institute of India, Ltd. for Exclusive Rights to Products and Utilization of MabIgX® Platform Technology Calcivis EDINBURGH, Scotland, Sept. 4, 2019 /PRNewswire/ --CALCIVIS Completes £4.5 Million Fund Raising Ahead of Anticipated PMA Approval of the CALCIVIS® Imaging System in the US Mobidiag FINLAND Espoo/CHINA, Zhengzhou, June 3 2019 – Mobidiag announces launch of Automobi Molecular Diagnostics Novuson BOTHELL, Wash., May 28, 2019 /PRNewswire/ -- Novuson Surgical, a Bothell, WA based medical device company, has secured funding from HOYA Corporation to finalize development for the UltraStat 3mm Vessel Sealer / Divider using Direct Therapeutic Ultrasound (DTU). Contact Us 1501 Century Avenue, Guohua Life Financial Tower, Shanghai kuan@lynx-capital.cn Name Email Message Submit Cookie Use We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies. Accept Learn More